The coronavirus disease (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected more than 233 million people worldwide and claimed over 4.7 million lives to date. While it is true that the approved vaccines…

Since the first reported coronavirus disease 2019 (COVID-19) case in December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome has continued to mutate and evolve. Some mutations in the SARS-CoV-2 genome might influence the development of effective intervention…

As the coronavirus disease 2019 (COVID-19) pandemic spread across the globe, it caused worldwide health and economic disasters. More quietly, mental health issues also began to increase in both quantity and severity, and there were strong concerns over potentially increasing…

Computational modeling of therapeutic targets is an important part of modern drug design and discovery. Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, the protein structure of the components of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…

Like many US states, Texas introduced many different measures to reduce the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), such as masking, social distancing, and the closure of public services and businesses likely to aid the spread of…

The coronavirus 19 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported in Wuhan, China in late 2019. Since then, COVID-19 has caused the deaths of more than 4.5 million people worldwide, along…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of the ongoing coronavirus disease (COVID-19) pandemic, was first reported in 2019 in Wuhan, China. Owing to the continual evolution of the virus as it circulates among the global population,…

Scientists have manufactured a synthetic form of peptide to combat viral infections, with successful tests already conducted on HSV-1 as well as SARS-CoV-2, showing no signs of cytotoxicity and improving the treatment of viral infections, with many potential applications. This…

Vaccines have proven effective in limiting the spread of coronavirus disease 2019 (COVID-19) and reducing the number of severe COVID-19 cases that lead to hospitalization or death. However, how vaccines affect the risk of developing long COVID remains poorly understood….

Many studies have reported lingering effects from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. These post-viral complications have come to be known as long-COVID. However, the rapid onset of the COVID-19 pandemic and rush to publish potentially helpful data…